Better Dividend: Merck & Co., Inc. (MRK) or Pfizer Inc. (PFE)?

Page 1 of 2

Merck & Co., Inc. (NYSE:MRK)‘s dividend yield is 4.2%. Pfizer Inc. (NYSE:PFE)‘s is only 3.5%. Merck’s is higher so it must be a better choice for dividend investors.

Not so fast.

Unless you’re content with a 4.2% yield, and you’re convinced that it can last long, you have to dig beyond the dividend yield to see which drugmaker is a better stock to own.

Merck & Co., Inc. (NYSE:MRK)A little history
Neither company has a stellar track record when it comes to dividends. They don’t compare to Abbott Laboratories¬†(NYSE:ABT), which raised its dividend for 40 years in a row, and probably would have continued the trend had it not spun off its pharmaceutical division into AbbVie Inc (NYSE:ABBV), sending a good chunk of its cash flow with it. Both Abbott and AbbVie will likely continue the tradition of raising their dividends, but they’ll do it from smaller individual bases.

Pfizer cut its dividend in half when it decided to purchase Wyeth in 2009. Since then, it’s made four dividend raises, but its dividend of $0.24 per quarter is still well below the $0.32 per quarter it handed out before the cut.

Merck hasn’t cut its dividend recently, but it doesn’t have a long history of raising it either. Merck’s dividend was frozen at $0.38 per quarter after Vioxx went off the market in 2004, until 2011, when Merck finally raised the dividend. It was raised again last year to the $0.43 it currently sits at.

Based on the free cash flow and dividends from the most recent reporting period — fourth quarter 2011 through third quarter 2012, because neither company has filed their 10-K for 2012 yet — it appears that both companies should have no problem funding the dividend in the future.

Company Dividend Payments TTM (in millions) Free Cash Flow TTM (in millions) Payout Ratio
Pfizer $6,439 $15,628 41%
Merck $5,001 $9,667 52%

Source: S&P Capital IQ.

Beyond the dividend
Investors shouldn’t be content with just the dividends. While the dividends pay out like a fairly nice bond, owning the stock comes with increased risk compared to a bond. You really need to supplement the dividend with capital appreciation of the stock to make owning either durgmaker worthwhile. Holding a large pharma isn’t risk free — Vioxx anyone? — so investors need to be rewarded for it; 3% to 4% return isn’t going to cut it.

Figuring out which company will increase its valuation is a little more complicated than analyzing the prospects for the dividend. There’s a lot of moving parts: revenue growth from current drugs, the company’s pipelines, drugs going off patent, changes in margins.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!